
Company Performance - Canopy Growth Corporation (CGC) stock increased by 1.94% to $1.05, outperforming the S&P 500 which fell by 1.6% [1] - Over the past month, CGC shares have decreased by 19.53%, while the Medical sector declined by 3.44% and the S&P 500 rose by 2.25% [1] Upcoming Financial Results - Canopy Growth Corporation is set to announce its earnings on August 8, 2025, with projected earnings of -$0.15 per share, reflecting a year-over-year growth of 59.46% [2] - The consensus estimate anticipates revenue of $47.91 million, indicating a 0.99% decrease from the same quarter last year [2] Full Year Estimates - For the full year, analysts expect earnings of -$0.46 per share and revenue of $198.45 million, representing changes of +84.56% and +2.66% respectively from the previous year [3] Analyst Estimates and Market Sentiment - Recent changes to analyst estimates for Canopy Growth Corporation indicate a shifting business landscape, with positive revisions suggesting analyst optimism about profitability [4] - The Zacks Rank system, which assesses estimate changes, currently ranks Canopy Growth Corporation as 5 (Strong Sell), reflecting a 5.38% decrease in the consensus EPS estimate over the last 30 days [6] Industry Context - The Medical - Products industry, which includes Canopy Growth Corporation, has a Zacks Industry Rank of 183, placing it in the bottom 26% of over 250 industries [7]